老年肺炎诊断与治疗中国专家共识(2024版)
中国已进入老龄化社会,老年人是肺炎高危人群。本共识以问答形式阐述17个临床问题,提出13条推荐意见,涵盖老年肺炎的病因、发病机制、诊断、病情评估、治疗和预防,旨在为防治老年肺炎、改善生活质量、降低住院及病死率提供参考。
要点
- 老年肺炎起病隐匿、症状不典型,需尽早行胸部CT等综合评估。
- 抗菌治疗应依据PK/PD和TDM进行个体化精准用药。
- 推荐老年人每年接种流感疫苗、肺炎球菌疫苗和新冠疫苗。
核心结论
- 本共识提出了13条推荐意见,涵盖老年肺炎的病因、发病机制、诊断、病情评估、治疗和预防,以期为防治老年肺炎提供参考。
研究设计与样本
- 本共识参照国内外最新相关指南与共识,结合该研究领域的最新进展制定。
- 以问答形式阐述了17个临床诊断、治疗和预防的问题。
主要发现
- 老年肺炎具有起病隐匿、进展迅速、合并症多、预后差、发病率和病死率高等特点。
- 老年肺炎主要风险因素包括年龄(推荐等级ⅠA)、年龄相关的全身因素(如体质差、基础疾病、合并用药)和特定因素(如吞咽困难和误吸),风险随年龄递增(推荐等级Ⅱ-1A)。
- 老年肺炎常起病隐匿、呼吸道症状不典型,尤其超高龄患者,初期可表现为乏力、食欲减退和意识障碍(推荐等级ⅢA)。
- 合并症比例高显著增加肺炎风险,尤其耐药菌所致肺炎,且预后更差(推荐等级Ⅱ-2A)。
- 神经系统或精神疾病及抗精神病药物等治疗药物增加老年患者吸入性肺炎、坏死性肺炎、肺脓肿、坠积性肺炎和肺不张风险(推荐等级Ⅱ-2B)。
关键数值与推荐
- 推荐1:老年肺炎主要风险因素包括年龄(推荐等级ⅠA)、年龄相关全身因素和特定因素(吞咽困难和误吸),风险随年龄递增(推荐等级Ⅱ-1A)。
- 推荐2:老年肺炎常起病隐匿、呼吸道症状不典型(推荐等级ⅢA);合并症比例高增加肺炎风险及不良预后(推荐等级Ⅱ-2A);神经精神疾病及抗精神病药物增加吸入性肺炎等风险(推荐等级Ⅱ-2B)。
- 推荐3:长期卧床、吸入性肺炎或病毒性肺炎的疑似老年肺炎患者应尽早行胸部CT(推荐等级ⅢA);常规检测未明确病原且经验性治疗无效等情况,建议侵入性操作获取BALF等并同步行分子生物学检测(推荐等级ⅢA)。
- 推荐4:应根据老年人生理特点评估抗菌药物PK变化及减量必要性,结合PK/PD和TDM指导个体化精准处方(推荐等级Ⅱ-2B)。
- 推荐5:确诊后应尽快开始经验性抗微生物治疗,除轻症门诊患者外应及时送检呼吸道分泌物和血标本;流感季节应及时开始经验性抗病毒治疗(推荐等级Ⅱ-1A)。
临床怎么用
- 对疑似老年肺炎患者,尤其长期卧床、吸入性肺炎或病毒性肺炎,应尽早行胸部CT。
- 抗菌药物使用应结合PK/PD和TDM进行个体化精准处方,确保疗效并减少不良反应。
- 评估吞咽能力,对吞咽困难者进行吞咽康复,采取半卧位、增稠流体和软食等措施减少误吸风险。
- 推荐老年人每年接种流感疫苗(ⅠA)、PPV23或PCV13预防CAP(ⅠB),并按国家指南接种新冠疫苗(ⅠA)。
- 老年人应戒烟、限酒、适度运动、定期口腔检查、保持营养和个人卫生,避免与急性病毒性呼吸道感染儿童密切接触。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
China is experiencing a demographic shift as its population ages. The elderly population becomes increasingly susceptible to pneumonia. Pneumonia in the elderly is characterized by its insidious onset, rapid progression, multiple comorbidities, poor prognosis, and high morbidity and mortality. Physicians need to pay attention to developing more comprehensive diagnostic evaluations and treatment strategies, and ensuring personalized care to the greatest extent. In order to improve the prevention and management of pneumonia in elderly, this consensus incorporates the latest guidelines and consensus from both domestic and international sources. The latest progress in this research field is also included. The document addresses 17 clinical issues in a question-and-answer format and provides 13 recommendations on the etiology, pathogenesis, clinical diagnosis, treatment, and prevention of pneumonia in older adults. It provides reference for the prevention and treatment of pneumonia in elderly, improving their quality of life, reducing hospitalization and mortality, and promoting healthy aging. The specific recommendations are as follows.Recommendation 1:The main risk factors for pneumonia in the elderly include age (Recommended Level ⅠA), age-related systemic factors (such as poor physical condition, underlying diseases, and concomitant medications), and specific factors (specifically dysphagia and aspiration). The risk increases progressively with age (Recommended Level Ⅱ-1A).Recommendation 2:Pneumonia in elderly individuals often presents with an insidious onset and atypical respiratory symptoms, especially in super-elderly patients. Initially, symptoms may include fatigue, loss of appetite, and disturbance of consciousness. Moreover, elderly patients often have underlying conditions such as pulmonary, cardiovascular, and neurological disorders, which can lead to rapid deterioration, multiple complications and sequelae. Pneumonia-related laboratory parameters in the elderly lack typical characteristic changes (Recommended Level ⅢA). The high proportion of comorbidities significantly increases the risk of pneumonia, especially pneumonia caused by drug-resistant bacteria, and the likelihood of a worse prognosis in elderly patients (Recommended Level Ⅱ-2A). Neurological or psychiatric disorders and therapeutic drugs such as antipsychotic drugs increase the risk of pneumonia including aspiration pneumonia, necrotizing pneumonia, lung abscess, hypostatic pneumonia and atelectasis in elderly patients (Recommended Level Ⅱ-2B).Recommendation 3:For elderly patients with suspected pneumonia, chest CT should be performed as early as possible in cases of long-term bed-ridden patients, aspiration pneumonia, or viral pneumonia (Recommended Level ⅢA). If conventional tests fails to identify the pathogen and empirical treatment proves to be ineffective, or if special pathogen infection such as viruses, severe or complex infection, or immunosuppression is suspected, it is advised to use invasive procedures to obtain bronchoalveolar lavage fluid (BALF), pleural effusion, or lung biopsy, and to conduct molecular biology testing (PCR, mNGS, tNGS, etc.) concurrently with conventional pathogen tests (Recommended Level ⅢA).Recommendation 4:The pharmacokinetics (PK) changes of antimicrobial drugs in elderly patients and necessity of dosage reduction should be evaluated according to the unique physiological characteristics of the elderly, such as declining body function, the presence of multiple diseases, and potential medication interactions. It is recommended to combine the PK/PD characteristics of antimicrobial drugs and therapeutic drug monitoring (TDM) methods to guide the individualized and precise prescription for elderly patients with pneumonia. This approach aims to ensure efficacy, minimizing the risk of bacterial resistance, and reduce the incidence of adverse reactions (Recommended Level Ⅱ-2B).Recommendation 5:Timing of treatment: Empiric antimicrobial therapy should be initiated as soon as the diagnosis is made. Except for outpatient clinic visitors with mild symptoms, properly collected respiratory secretions and blood samples should be sent without delay for pathogenic microorganisms testing. During the influenza season, timely empiric antiviral therapy should be initiated without positive result (Recommended Level Ⅱ-1A).Recommendation 6:Coverage of possible pathogens: Due to the increased detection rate of various pathogens such as gram-negative bacteria, anaerobic bacteria, fungi, etc., the initial treatment should cover the possible pathogens. Individualized treatment should be started according to the estimation of drug resistance risk, the of PK/PD principle, and potential drug side effects (Recommended Level Ⅱ-1A).Recommendation 7:Appropriate treatments for promoting sputum drainage and airway clearance in elderly pneumonia patients should be chosen after a comprehensive evaluation of the patient's condition. It is crucial to assess the patient's coughing efficacy to avoid asphyxia (Recommended Level ⅢA).Recommendation 8:We recommend cautious use of glucocorticoids in elderly pneumonia patients. When it is indeed necessary to use glucocorticoids in severe pneumonia cases accompanied by septic shock and hemodynamic instability, it's crucial to tailor drug regimens carefully, monitor closely for adverse reactions, and avoid excessive or prolonged glucocorticoid use (Recommended Level ⅢB).Recommendation 9:Assessing the swallowing abilities of elderly patients is important, and individuals with dysphagia should undergo swallowing rehabilitation. These measures can help reduce the risk of aspiration pneumonia, such as adopting a semi-recumbent posture, thickened fluids and soft foods, proper dental care, tube feeding, and discontinuing medications that increase the risk of aspiration pneumonia in older patients (Recommended Level ⅡA).Recommendation 10:We recommend that elderly individuals get an annual influenza virus vaccine (Recommended Level ⅠA), 23-valent pneumococcal polysaccharide vaccine (PPV 23) or the 13-valent pneumococcal conjugate vaccine (PCV 13) to prevent CAP (Recommended Level ⅠB), and COVID-19 vaccine should also be recommended in accordance with national guidelines (Recommended Level ⅠA).Recommendation 11:Older individuals should quit smoking, limit alcohol intake, participate in moderate-intensity physical activity (Recommended Level Ⅱ-1A), have regular dental examinations, maintain good nutritional status and personal hygiene, and avoid close contact with children with acute viral respiratory infections (Recommended Level Ⅱ-2A).Recommendation 12:The super-elderly are more likely to experience geriatric syndromes, particularly sarcopenia and frailty, which are closely associated with the occurrence of aspiration pneumonia. Preventing and improving sarcopenia and weakness through nutrition supplement, exercise, cognitive training, etc., can effectively reduce the incidence of pneumonia (Recommended Level ⅢA).Recommendation 13:We recommend that older adults with chronic underlying medical conditions, who are at increased risk of developing pneumonia, should receive personalized management and comprehensive preventive measures to strengthen the management of underlying diseases. Perioperative care for older patients should be optimized to reduce the risk of postoperative pneumonia (Recommended Level ⅢA). 中国已经进入老年化社会,而老年人是罹患肺炎的高危人群。老年肺炎具有起病隐匿、进展迅速、合并症多、预后差、发病率和病死率高等特点,需要引起临床医师的重点关注,制定更为精细的诊治策略,最大程度地保证个体化治疗。为加强对老年肺炎的防治与管理,本共识参照国内外最新相关指南与共识,结合该研究领域的最新进展,以问答的方式阐述了17个临床诊断、治疗和预防的问题,提出了13条推荐意见,从老年肺炎的病因及发病机制、诊断、病情评估、治疗和预防等方面提出意见和建议,以期为防治老年肺炎,改善老年患者的生活质量,降低住院及病死率,促进健康老龄化提供参考。.
引用
- [Chinese expert consensus on the diagnosis and treatment of pneumonia in the elderly (2024 Edition)]. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 39757093. doi:10.3760/cma.j.cn112147-20240611-00328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。